研究業績
-
2024年01月04日The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells
-
2024年01月04日Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors
-
2024年01月04日iPS細胞を用いたがんに対する免疫療法
-
2024年01月04日iPS細胞を使った “off-the-shelf” CAR-T細胞の開発
-
2024年01月04日Engineering of human induced pluripotent stem cells via human artificial chromosome vectors for cell therapy and disease modeling.
-
2024年01月04日Current status and future perspectives of HLA-edited induced pluripotent stem cells.
-
2024年01月04日Non-clinical efficacy, safety, and stable clinical cell processing of iPSC-derived anti-GPC3 CAR-expressing NK/ILC cells.
-
2024年01月04日Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response
-
2024年01月04日Podoplanin as an attractive target of CAR-T cell therapy.
-
2024年01月04日In vitro detection of cellular adjuvant properties of human invariant natural killer T cells.
-
2024年01月04日In vitro differentiation of T cells: From non-human primate-induced pluripotent stem cells.
-
2024年01月04日In vitro differentiation of T cells: From CAR-modified T-iPSC.
